Sironax
Sironax develops therapies for neurodegenerative, inflammatory, immunologic, metabolic, and rare diseases.
$200M Series B+ ·
Source: fundraisingfox.com
Latest round on record: Series B+, September 2025, amount undisclosed.
All 2 rounds ↓Signals
About Sironax
It conducts clinical studies of SIR2501, SIR4156, and SIR9900. Sironax also develops the Brain Delivery Module platform. Its customers are patients with these diseases.
Sironax | 1567 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com | |
| Series B+ | $200M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Founders and team
- XWXiaodong Wang Foundersource: sironax.com
ZZ
Zhiyuan Zhang FounderLinkedIn · source: sironax.com
Companies like Sironax
AActio Biosciences$66M Series B+ · Jun 2025
MMwyngil TherapeuticsSeed · Jun 2026
HHotSpot Therapeutics$100M Series B+ · Nov 2021
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
AAlzheon$100M Series B+ · Apr 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sironax (get a free API key).